HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤ 40 IU/L and significant hepatic fibrosis.

AbstractBACKGROUND:
Chronic hepatitis B (CHB) may lead to cirrhosis, hepatocellular carcinoma and premature death. Elevated alanine transaminase (ALT) levels ≥ the upper limit of normal (ULN) are a major determinant for initiating anti-viral therapy; however, ALT levels alone may not be predictive of hepatic fibrosis.
AIM:
To determine the proportion of CHB patients with ALT ≤ 40 IU/L and liver fibrosis stage ≥ 2. Secondary goals include subgroup analysis by hepatitis B e antigen (HBeAg) status, high hepatitis B virus (HBV) DNA levels, Asian ethnicity, lower ULN of ≤ 30 IU/L (males) and 19 IU/L (females), and advanced age.
METHODS:
Studies identified in EMBASE and MEDLINE (1/1990-6/2012) using the search criteria: "Hepatitis B"[Mesh] OR "Hepatitis B virus"[Mesh] OR "Hepatitis B, Chronic"[Mesh])) AND "Alanine Transaminase"[Mesh]) and abstracts containing the term 'hepatitis' from recent major U.S. gastroenterology and liver society meetings were considered.
RESULTS:
Among nine studies (N = 830 patients), a significant proportion (20.7%; 95% CI: 16.2-26.0%) of CHB patients with ALT levels ≤ 40 IU/L had significant fibrosis irrespective of HBeAg status, high HBV DNA levels, ethnicity or age, although this proportion may be higher in patients older than 30-40 years old. The corresponding proportion was 27.8% even when the newer ULN of 30 IU/L (males) and 19 IU/L (females) was applied.
CONCLUSIONS:
Approximately one fifth of CHB patients with ALT ≤ 40 IU/L may have significant hepatic fibrosis. The approach to such patients should be individualised, as further evaluation and treatment may be appropriate.
AuthorsD T Chao, J K Lim, W S Ayoub, L H Nguyen, M H Nguyen
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 39 Issue 4 Pg. 349-58 (Feb 2014) ISSN: 1365-2036 [Electronic] England
PMID24387289 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
Copyright© 2014 John Wiley & Sons Ltd.
Chemical References
  • DNA, Viral
  • Hepatitis B e Antigens
  • Alanine Transaminase
Topics
  • Adult
  • Alanine Transaminase (blood)
  • DNA, Viral (blood)
  • Female
  • Hepatitis B e Antigens (blood)
  • Hepatitis B virus (isolation & purification)
  • Hepatitis B, Chronic (complications, physiopathology)
  • Humans
  • Liver Cirrhosis (epidemiology, etiology)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: